Pentwater Capital Management’s GeneDx Holdings WGS Stock Holding History

Pentwater Capital Management’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-50,000	Closed	-$6.5M	–	121
2025 Q4	$6.5M	Sell	50,000 -290,000	-85%	-$39.8M	0.03%	63
2025 Q3	$36.6M	Sell	340,000 -690,000	-67%	-$75.2M	0.2%	58
2025 Q2	$95.1M	Buy	1,030,000 +1,005,000	+4,020%	+$78.9M	0.62%	32
2025 Q1	$2.21M	Buy	+25,000	New	+$2.17M	0.02%	86

Other funds holding WGS

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Pentwater Capital Management's WGS Position: Q2 2026 in Review

Pentwater Capital Management opened a new position in GeneDx Holdings (WGS) in Q2 2026: 82,500 shares worth $5.66M. The stake represents 0.03% of the portfolio and ranks #69 among its holdings. This is a return to the name: Pentwater Capital Management previously reported a position in WGS as recently as Q4 2025.

Pentwater Capital Management first reported a position in WGS in Q1 2025 and has held it in 5 quarters since. The position peaked at $113M in Q2 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

Pentwater Capital Management held 82,500 shares of GeneDx Holdings worth $5.66M as of Q2 2026.
GeneDx Holdings was a new Pentwater Capital Management position in Q2 2026.
GeneDx Holdings made up 0.03% of Pentwater Capital Management's portfolio in Q2 2026, its #69 holding.
Pentwater Capital Management first reported a position in GeneDx Holdings in Q1 2025 and has held it in 5 quarters since.
Pentwater Capital Management's GeneDx Holdings position peaked at $113M in Q2 2025.
223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Pentwater Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.